Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

Procter & Gamble Co / Equity Capital Markets

<ul><li>For many years now, P&G has been considered a solid defensive stock and the Covid-19 pandemic re-emphasized this fact.</li><li>For the year 2021, the company managed to deliver a decent top-line growth and sequential earnings progress despite significant cost headwinds, and continued strong cash productivity.</li><li>They have been able to deliver category growth through constant product innovation and superior execution.</li></ul>

For many years now, P&G has been considered a solid defensive stock and the Covid-19 pandemic re-emphasized this fact.For the year 2021, the company managed to deliver a decent top-line growth and sequential earnings progress despite significant cost headwinds, and continued strong cash productivity.They have been able to deliver category growth through constant product innovation and superior execution.

Procter & Gamble Co.: Financial & Price Forecasts

<ul><li>Consumer goods companies are currently facing their fair share of challenges in terms of rising input costs associated with the U.S. inflation being at an all-time high (close to 6.8%), labor issues, and supply chain problems.</li><li>Both these companies enjoyed their fair share of benefits during the pandemic lockdowns with their product range being classified in the 'essentials' category.</li><li>However, it would be interesting to place them side-by-side and evaluate the more financially robust player of the two.</li></ul>

Consumer goods companies are currently facing their fair share of challenges in terms of rising input costs associated with the U.S. inflation being at an all-time high (close to 6.8%), labor issues, and supply chain problems.Both these companies enjoyed their fair share of benefits during the pandemic lockdowns with their product range being classified in the 'essentials' category.However, it would be interesting to place them side-by-side and evaluate the more financially robust player of the two.

Procter & Gamble vs. Kimberly-Clark: Which Consumer Goods Major Is Financially More Stable? (12/2021)

Value Investing

Vladimir Dimitrov, CFA

Equity Bottom-Up

<ul>
<li>Reckitt Benckiser has been one of the worst performers in the large cap household &amp; personal products space.</li>
<li>Past mistakes in strategic capital allocation are still lingering over the business, while debt levels will likely require more divestments.</li>
<li>The business, however, is in a good position to regain shareholders' trust and its leading position in the industry.</li>
</ul>


Reckitt Benckiser has been one of the worst performers in the large cap household &amp; personal products space.
Past mistakes in strategic capital allocation are still lingering over the business, while debt levels will likely require more divestments.
The business, however, is in a good position to regain shareholders' trust and its leading position in the industry.


Reckitt Benckiser - Still Paying For Past Mistakes

<ul><li>Procter &amp; Gamble is unlikely to repeat its stellar performance of recent years, however, it is an excellent wealth preservation vehicle.</li><li>From a macroeconomic point of view, 2022 has the early signs of a strong year for consumer staples.</li><li>P&amp;G is also well-positioned to retain its high profitability and asset efficiency, which for now puts a floor to its valuation.</li></ul>

Procter &amp; Gamble is unlikely to repeat its stellar performance of recent years, however, it is an excellent wealth preservation vehicle.From a macroeconomic point of view, 2022 has the early signs of a strong year for consumer staples.P&amp;G is also well-positioned to retain its high profitability and asset efficiency, which for now puts a floor to its valuation.

Procter & Gamble: The Pinnacle Of Capital Preservation

<ul><li>Consumer goods as a sector is hurting from lower margins as a result of the rising cost inflation and Procter & Gamble is no exception to this rule.</li><li>P&G’s positive revenue performance was a function of strength across all segments coupled with robust volume, pricing and mix, and a favorable impact of foreign currency fluctuations.</li><li>The management’s expectation of a continued rise in input costs does add a certain amount of pessimism to the stock.</li></ul>

Consumer goods as a sector is hurting from lower margins as a result of the rising cost inflation and Procter & Gamble is no exception to this rule.P&G’s positive revenue performance was a function of strength across all segments coupled with robust volume, pricing and mix, and a favorable impact of foreign currency fluctuations.The management’s expectation of a continued rise in input costs does add a certain amount of pessimism to the stock.

United States

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Procter & Gamble Co (PG US)

Procter & Gamble Co.: Financial & Price Forecasts

For many years now, P&G has been considered a solid defensive stock and the Covid-19 pandemic re-emphasized this fact. For the year 2021, the...

Baptista Research

Procter & Gamble vs. Kimberly-Clark: Which Consumer Goods Major Is Financially More Stable? (12/2021)

Consumer goods companies are currently facing their fair share of challenges in terms of rising input costs associated with the U.S. inflation...

Baptista Research

Reckitt Benckiser - Still Paying For Past Mistakes

Reckitt Benckiser has been one of the worst performers in the large cap household & personal products space. Past mistakes in strategic...

Vladimir Dimitrov, CFA

Procter & Gamble: The Pinnacle Of Capital Preservation

Procter & Gamble is unlikely to repeat its stellar performance of recent years, however, it is an excellent wealth preservation vehicle. From...

Vladimir Dimitrov, CFA

Procter & Gamble Co - Investment Thesis

Consumer goods as a sector is hurting from lower margins as a result of the rising cost inflation and Procter & Gamble is no exception to this...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)